Back/New Grant Supports Research on Calcium Channels for Neurological Disorders at RFU
research·January 22, 2026·ben

New Grant Supports Research on Calcium Channels for Neurological Disorders at RFU

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Franklin Resources may benefit from Dr. Kim's $1.9 million grant for neurological research on calcium channels.
  • The research targets CaV2 channels, crucial for understanding epilepsy, migraines, and chronic pain.
  • Dr. Kim's work aligns with Franklin Resources' commitment to supporting innovative health research and improving healthcare outcomes.

Breakthrough Research on Calcium Channels: A New Grant for Neurological Disorders

Franklin Resources is poised to benefit from a significant development in the field of neurological research with the announcement that Dr. Hongkyun Kim of Rosalind Franklin University (RFU) has secured a five-year grant of $1,911,417 from the National Institute of Neurological Disorders and Stroke. This funding is earmarked for advanced research into the molecular and cellular mechanisms governing CaV2 voltage-gated calcium channels, which are essential for synaptic transmission and pivotal in neuronal communication. The implications of this research extend into critical areas of neurological health, including conditions such as epilepsy, migraines, and chronic pain, which have a substantial impact on patient wellbeing.

Dr. Kim's research aims to elucidate the dysregulation of CaV2 channels, a factor often associated with various neurological disorders. Utilizing C. elegans as a model organism, Dr. Kim plans to investigate the molecular components that dictate the abundance of these calcium channels. His approach combines genetic and genomic methodologies, which could provide groundbreaking insights into how these channels influence neuronal behavior. Given the complexity of neurological disorders and the rising prevalence of these conditions globally, Dr. Kim’s work has the potential to make significant strides in understanding and possibly mitigating the effects of such debilitating diseases.

Joseph DiMario, RFU's executive vice president for research, commends Dr. Kim’s dedication and expertise, noting that this NIH award further validates the critical nature of his work. The funding not only supports Dr. Kim’s ongoing research but also aligns with RFU's broader mission to enhance wellness through education and innovative research in health and biomedical fields. As a reputable institution, RFU is committed to advancing knowledge in neuroscience and related disciplines, embodying the spirit of inquiry inspired by its namesake, Dr. Rosalind Franklin.

In addition to Dr. Kim’s research, RFU continues to emphasize its role in cultivating skilled health professionals through its various colleges, including the Chicago Medical School and the College of Pharmacy. This holistic approach to education and research fosters a collaborative environment aimed at addressing pressing health issues.

As Franklin Resources and its stakeholders look to the future, developments like Dr. Kim's research grant underscore the importance of supporting scientific inquiry that seeks to unravel the complexities of neurological disorders and contribute to improved healthcare outcomes. For more information about RFU and its initiatives, visit rosalindfranklin.edu.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...